By the end of this topic, the student should be able to:
Goal setting within the recovery process often involves the SMART approach, which is an acronym that ensures goals are Specific, Measurable, Action oriented, Realistic, and Time bound (Bovend'Eerdt et al., 2009).
Goal setting is an important component of recovery and is best done collaboratively with the individual. Using a person-centred approach is essential to ensure that individuals explore their own experiences openly to reach goals that are:
If a trusting relationship is absent, or the health and social service provider assumes a dominant role in goal setting, conflict can emerge, or goals may reflect the needs of the specific program (for example, be tailored to success rates) rather than what is best for the individual.
It is critical for the health and social service provider to show respect for and acceptance of the goals the individual establishes and to refrain from negotiating “higher” goals that may be unattainable and will reduce or threaten the process of self-efficacy.
Goal setting requires health and social service providers to be mindful of their own bias and values; they do not suggest goals that maybe beyond the capability of the client.
“Self-efficacy involves building up patients' belief in their ability to carry out or succeed with a specific task. This means providing a sense of optimism, often by setting a series of simple, attainable early goals toward recovery that will increase the substance-abusing patient's self-confidence when accomplished”
Smart goals are short, clear, and identified by the person rather than by the provider. Each criterion (i.e., Specific, Measurable, Action oriented, Realistic, and Time bound) typically has only one to two small goals to support success (see examples below).
Respectful dialogue with the individual is important when establishing the SMART goals. The principles of motivational interviewing can be used as a guide is identifying goals as seen below.
Component | Example |
---|---|
Specific | I will attend a weekly peer meeting as a form of support. |
Measurable | I will keep a calendar of attendance. I will gain more self-confidence as a result of attending. |
Action Oriented | I will make the necessary work and family arrangements to attendance regularly. |
Realistic | If I feel sick or unwell, I will give myself permission to not attend. |
Time Bound | I will attend weekly support meetings for the next six months at which time I will review with my [physician, counsellor, social worker, peer support, coach, etc.]. |
The health and social service provider can support goal establishment by keeping the general principals of motivational interviewing in mind (Center for Substance Abuse Treatment, 1999):
nito100/iStock
Informed consent is defined as an informed decision to accept or refuse treatment and is an important component of the treatment process.
Informed consent is imperative, as it:
At a few transitional stages in opioid therapy, informed consent may need to be initiated or revisited. For example, informed consent could be obtained:
It is critical that the person using opioids is free to make the decision regarding their treatment without internal or external coercion; thus, respecting and empowering the client will be key to informed decision-making.
The format, content, and time taken during this process will vary among clients depending on their capacity to understand, reasons for treatment, and previous experience with opioid therapy.
NOTE: Opioid addiction may hinder the ability to give informed consent. The client should not be intoxicated or suffering from acute withdrawal symptoms when consent is obtained.
Elements involved in informed decision-making (informed consent) include the following (Hall et al., 2012):
Clients may request or seek out supplementary resources when making decisions regarding their treatment or treatment of their loved one. Conducting an open dialogue about community resources that are freely available and accessible can help create a solid foundation to build upon during this process.
Take a moment to browse some existing online resources that could be recommended:
Institute for Safe Medication Practices (ISMP) Canada:
Opioid Pain Medicine—Information for Patients and Families (PDF)
Opioids for Pain After Surgery: Your Questions Answers (PDF)
Choosing Wisely Canada
Opioids—When You Need Them and When You Don't
Canadian Association for Mental Health (CAMH) Provincial System Support Program
Preventing Opioid Overdose (PDF)
Government of Canada
Now that you have reviewed this content, try this:
Propose a SMART goal for improving the health outcome of a client
Consider client-centered, collaborative ways this could be achieved.
American Medical Association. Informed consent. (n.d.). https://www.ama-assn.org/delivering-care/ethics/informed-consent Bovend'Eerdt, T., Botell, R., & Wade, D. (2009). Writing SMART rehabilitation goals and achieving goal attainment scaling: A practical guide. Clinical Rehabilitation, 23(4), 352–361. https://doi.org/10.1177/0269215508101741
Carter, A., & Hall, W. (2008). Informed consent to opioid agonist maintenance treatment: recommended ethical guidelines. International Journal of Drug Policy, 19(1), 79–89.
Center for Substance Abuse Treatment. (1999). Motivational interviewing as a counseling style. In Enhancing motivation for change in substance abuse treatment (Treatment Improvement Protocol Series, No. 35) (Chapter 3). U.S. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64964/
Cheatle, M. D., & Savage, S. R. (2012). Informed consent in opioid therapy: A potential obligation and opportunity. Journal of Pain and Symptom Management, 44(1), 105–116.
Chisholm-Burns, M. A., Kim Lee, J., Spivey, C. A., Slack, M., Herrier, R. N., Hall-Lipsy, E., Graff Zivin, J., Abraham, I., Palmer, J., Martin, J. R., Kramer, S. S., & Wunz, T. (2010). US pharmacists’ effect as team members on patient care: Systematic review and meta-analysis. Medical Care, 48(10), 923–933.
Giannitrapani, K. F., Fereydooni, S., Azarfar, A., Silveira, M. J., Glassman, P. A., Midboe, A. M., Bohnert, A. B. S., Zenoni, M. A., Kerns, R. D., Pearlman, R. A., Asch, S. M., Becker, W. C., & Lorenz, K. A. (2020). Signature informed consent for long-term opioid therapy in patients with cancer: perspectives of patients and providers. Journal of Pain and Symptom Management, 59(1), 49–57.
Hall, D. E., Prochazka, A. V., & Fink, A. S. (2012). Informed consent for clinical treatment. CMAJ, 184(5), 533–540.
Jacobson, P. L., & Mann, J. D. (2004). The valid informed consent-treatment contract in chronic non-cancer pain: Its role in reducing barriers to effective pain management. Comprehensive Therapy, 30(2), 101–104.
Laudet, A. B. (2007). What does recovery mean to you? Lessons from the recovery experience for research and practice. Journal of Substance Abuse Treatment, 33(3), 243–256. https://doi.org/10.1016/j.jsat.2007.04.014
Ontario College of Pharmacists. (n.d.). Opioids. https://www.ocpinfo.com/practice_resource/opioids/
Swenson, C. N., & Poffenberger N. Development of a collaborative practice for management of chronic nonmalignant pain.
Weaver, M. F., Jarvis, M., & Schnoll, S. H. (1999). Role of the primary care physician in problems of substance abuse. Archives Internal Medicine, 159(9), 913–924. https://doi.org/10.1001/archinte.159.9.913